These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21818068)

  • 1. Abuse-resistant painkillers get mixed FDA response.
    Waters H
    Nat Med; 2011 Aug; 17(8):905. PubMed ID: 21818068
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone.
    Bailey JE; Barton PL; Lezotte D; Lowenstein SR; Dart RC
    Drug Alcohol Depend; 2006 Sep; 84(2):182-7. PubMed ID: 16510252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposed FDA rules on painkillers in U.S. Rile cancer community.
    Brower V
    J Natl Cancer Inst; 2009 Oct; 101(20):1376-7. PubMed ID: 19797722
    [No Abstract]   [Full Text] [Related]  

  • 4. Addressing OxyContin abuse.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692884
    [No Abstract]   [Full Text] [Related]  

  • 5. States respond to growing abuse of painkiller.
    Wasserman S
    State Legis; 2001; 27(9):33-4. PubMed ID: 11763873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumer group urges Food and Drug Administration to ban drug Darvon.
    Willens JS
    Pain Manag Nurs; 2006 Jun; 7(2):43. PubMed ID: 16730316
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription drug abuse: FDA and SAMHSA join forces.
    Meadows M
    FDA Consum; 2003; 37(2):36. PubMed ID: 12715769
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA actions to prevent prescription drug abuse.
    Jeske AH
    Tex Dent J; 2005 Jul; 122(7):634-45. PubMed ID: 16152888
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA chief defends Zohydro approval as US states rebel.
    McCarthy M
    BMJ; 2014 Apr; 348():g2939. PubMed ID: 24764572
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA acts to reduce harm from opioid drugs.
    J Pain Palliat Care Pharmacother; 2011; 25(3):296-7. PubMed ID: 21882983
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA is urged to reverse its approval of new pain drug Zohydro ER.
    McCarthy M
    BMJ; 2014 Mar; 348():g1894. PubMed ID: 24591422
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid medication management: clinician beware!
    Jamison RN; Clark JD
    Anesthesiology; 2010 Apr; 112(4):777-8. PubMed ID: 20216398
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA asks Purdue Pharma to withdraw Palladone.
    FDA Consum; 2005; 39(5):7. PubMed ID: 16419284
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care.
    Katz MH; Kotabe S
    Med Care; 2008 Sep; 46(9):1002. PubMed ID: 18725857
    [No Abstract]   [Full Text] [Related]  

  • 15. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA panel debates merits of next-generation opioid formulations.
    Lavine G
    Am J Health Syst Pharm; 2009 Jan; 66(1):8-11. PubMed ID: 19106336
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended-release hydrocodone (Zohydro) for pain.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncologists want FDA to rethink REMS.
    Goozner M
    J Natl Cancer Inst; 2010 Dec; 102(23):1748-9, 1751. PubMed ID: 21088276
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration risk evaluation and mitigation strategy.
    Craig DS
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):145-8. PubMed ID: 20504137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic pain, addiction, and Zohydro.
    Olsen Y; Sharfstein JM
    N Engl J Med; 2014 May; 370(22):2061-3. PubMed ID: 24758596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.